Mandate

Investor buys out part of Neoventa Medical

July 21, 2006

Investor Growth Capital and CapMan are investing in Neoventa Medical AB, a Swedish medical technology company in the field of fetal monitoring. Investor Growth Capital and CapMan will hold approximately 30% each of the share capital, while the majority of the remaining shares will be owned by SEK Företagsinvest as previous. The new ownership constellation provides the company with SEK 75 million to finance the next phase in Neoventa's growth - focusing on the American market.

Vinge acted as advisor to Neoventa Holding AB. Vinge representatives included Johan Winnerblad, Marcus Axelryd and Theresa Kovac.

Related

Vinge advises ABG Sundal Collier in connection with Conapto's issue of subsequent senior secured bonds of SEK 500 million

Vinge has advised ABG Sundal Collier as arranger in connection with Conapto Holding AB (publ)'s issue of subsequent senior secured bonds of SEK 500 million under the existing framework of SEK 2 billion.
April 24, 2026

Vinge advises GBL on its acquisition of BUKO Group

Vinge, together with Latham & Watkins, advises Groupe Bruxelles Lambert (“GBL”) (Euronext Brussels: GBLB) on its acquisition of BUKO Group, a leading platform in temporary traffic management, from funds advised by Equistone Partners Europe and the founding family, while management will re-invest alongside GBL. The transaction, which is subject to customary approvals, will entail a EUR 0.5 billion equity investment by GBL.
April 24, 2026

Vinge advise Lagercrantz Group on the business acquisition of FMK Trafikprodukter

Lagercrantz Group, through its subsidiary Nordic Road Safety, has entered into an agreement to acquire the business and assets of FMK Trafikprodukter – a niche company specialising in CE-certified road barrier systems for the Swedish and Nordic infrastructure market.
April 24, 2026